Micro-RNA Expression Profiles in Localised Prostate Cancer

Prostate Cancer Clinical Trial

Official title:

Micro-RNA Expression Profiles in Localised Prostate Cancer

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03338712
• Other study ID #: mi-RNA-PCa
• Status: Withdrawn
• Start date: February 1, 2010
• Est. completion date: April 1, 2016

Study information

• Verified date: November 2017
• Source: Wuerzburg University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Recurrence free survival The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: April 1, 2016
• Est. primary completion date: April 1, 2016
• Gender: Male
• Age group: 35 Years to 80 Years

Eligibility

Inclusion Criteria:

• 35 Years to 80 Years

• Male

• Patients with clinically localised high risk prostate cancer

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Prostate Cancer
• Prostatic Neoplasms
• Radical Prostatectomy

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Wuerzburg University Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Recurrence free survival	The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association.	Up to 120 months. From date of inclusion until date of death from any cause
Secondary	Cancer specific survival	Cancer specific survival	Up to 120 months. From date of inclusion until date of death from any cause